Pictured: ESK1 Monoclonal Antibody
New Molecule Targets Proteins Inside Cancer Cells

Scientists from Memorial Sloan Kettering have collaborated on the discovery of a unique monoclonal antibody, called ESK1, that appears to be effective at targeting and destroying several types of cancer cells.

Wednesday, March 13, 2013
Pictured: Charles Sawyers
Physician-Scientist Charles Sawyers Awarded Breakthrough Prize in Life Sciences

Charles Sawyers, Chair of Memorial Sloan Kettering’s Human Oncology and Pathogenesis Program, is a recipient of the inaugural $3 million prize for groundbreaking achievements in scientific research.

Wednesday, February 20, 2013
Pictured: Neurons
Researchers Identify Key Element of Nerve Cell Development

Researchers have clarified the process by which developing nerve cells are directed to specialize into distinct parts.

Monday, February 11, 2013
Pictured: BCG
Study Clarifies How Bladder Cancer Treatment Works

Researchers have shed light on how an important treatment for early-stage bladder cancer enters cancer cells to eradicate them.

Friday, February 1, 2013
Pictured: X-ray Image
New Findings Clarify How Kidney Cancer Spreads to Distant Organs

Scientists have identified genes and biological mechanisms that one day could be targeted with drugs to stop kidney cancer from spreading to the bone, brain, or other organs.

Wednesday, December 19, 2012
Pictured: Michel Sadelain
New Technique Could Make Cell-Based Immune Therapies for Cancer Safer and More Effective

Memorial Sloan Kettering researchers have reported a new method that could allow the development of more-specific, cell-based therapies for cancer.

Tuesday, December 18, 2012
Pictured: Ming Li
Study Suggests New Ways of Manipulating Immune System to Treat Autoimmune Diseases and Cancer

Recent findings by Memorial Sloan Kettering immunologists might one day pave the way for new strategies to control a range of diseases, including autoimmune disorders and cancer.

Friday, December 14, 2012
Pictured: Michel Sadelain & Jedd Wolchok
Memorial Sloan Kettering Researchers Appointed to Stand Up To Cancer Immunology “Dream Team”

Physician-scientists Michel Sadelain and Jedd Wolchok have been appointed to a new research team dedicated to investigating ways to harness the immune system to fight cancer.

Wednesday, December 12, 2012
Pictured: Lorenz Studer
Developmental Biologist Lorenz Studer Comments on the 2012 Nobel Prize in Physiology or Medicine

Methods to generate stem cells have given scientists new ways to study some diseases and identify potential drugs, and could one day be used to rebuild diseased or damaged tissues in patients.

Tuesday, December 11, 2012
Pictured: Charles Sawyers
President Obama Names Physician-Scientist Charles Sawyers to National Cancer Advisory Board

Charles Sawyers, Chair of Memorial Sloan Kettering’s Human Oncology and Pathogenesis Program, is widely recognized as someone who is revolutionizing the molecular treatment of cancer.

Saturday, December 8, 2012